NASH - Nonalcoholic Steatohepatitis Clinical Trials

114 clinical trials for NASH - Nonalcoholic Steatohepatitis across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH — RECRUITING · PHASE3
• Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis — RECRUITING · NA
• Non-Invasive Quantification of Liver Health in NASH (N-QUAN) — RECRUITING · NA
• A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients — RECRUITING · NA
• Semaglutide vs Sitagliptin — RECRUITING · PHASE4
• Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity — RECRUITING
• Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach — RECRUITING · NA
• Disease Prevention in Clinical Practice Base on Patient Specific Physiology — RECRUITING
• The European NAFLD Registry — RECRUITING
• PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies — RECRUITING
• Estrogen Administration for the Treatment of NASH in Postmenopausal Women — ACTIVE_NOT_RECRUITING · PHASE3
• A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry) — COMPLETED · PHASE2
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — ACTIVE_NOT_RECRUITING · PHASE3
• Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects — ACTIVE_NOT_RECRUITING · PHASE2
• Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis — TERMINATED · PHASE2
• Hepatic Energy Fluxes in NASH and NAS Patients — ACTIVE_NOT_RECRUITING · NA
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — ACTIVE_NOT_RECRUITING · PHASE3
• Phase 2a Study of HPG1860 in Subjects With NASH — COMPLETED · PHASE2
• Novel MRE Technique to Assess a Risk Factor for Liver Cancer — ACTIVE_NOT_RECRUITING
• Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis — ACTIVE_NOT_RECRUITING · NA
• Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis — COMPLETED · NA
• A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis — NOT_YET_RECRUITING · PHASE2
• Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE — COMPLETED
• Tocotrienol Against the Progression of End Stage Liver Disease — ACTIVE_NOT_RECRUITING · PHASE2
• Statins for the Treatment of NASH — ACTIVE_NOT_RECRUITING · PHASE2
• Nonalcoholic Fatty Liver Disease in HIV Database — ACTIVE_NOT_RECRUITING
• Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study — SUSPENDED
• The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease — COMPLETED · PHASE2
• Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) — COMPLETED · PHASE2
• Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome" — COMPLETED
• The Franciscus Obesity NASH Study — ACTIVE_NOT_RECRUITING
• Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD — WITHDRAWN · NA
• Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) — COMPLETED · PHASE2
• Pemvidutide (ALT-801) DDI Study in Healthy Volunteers — COMPLETED · PHASE1
• A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) — COMPLETED · PHASE2
• Mild Hypothermia and Acute Kidney Injury in Liver Transplantation — TERMINATED · NA
• LITMUS Imaging Study — ACTIVE_NOT_RECRUITING
• Spironolactone Therapy In Young Women With NASH — COMPLETED · PHASE1
• DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis — COMPLETED · PHASE2
• Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH — TERMINATED · PHASE1
• Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS) — NOT_YET_RECRUITING
• A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH) — COMPLETED · PHASE2
• Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH) — OTHER · PHASE2
• A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial — COMPLETED · PHASE2
• Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus — COMPLETED · PHASE2
• Pentoxifylline in Treatment of Patients With Nonalcoholic Steatohepatitis — COMPLETED · PHASE3
• A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH — COMPLETED · PHASE2
• AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis — COMPLETED · PHASE1
• Study to Evaluate MET642 in Patients With NASH — COMPLETED · PHASE2
• Gut Permeability and Bariatric-metabolic Surgery — OTHER

Refine this search